FDA Approves ROPINIROLE — Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited announced the FDA approval of generic ropinirole hydrochloride tablets, positioning the company to supply the oral Product and compete in the Parkinson's disease market. This ANDA approves a blockbuster medication expected to drive future revenue as the original brand patent expires.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed